The CI values across different dose combinations on the two cell lines were less than 1, implying that all combinations exhibited a synergistic effect (Khazaei and Pazhouhi, 2019)
3.2.2 Increasing Sensitivity to TAM and Reducing Resistance TAM is an endocrine drug that is most commonly used to block the effects of estrogen at all stages of breast cancer, especially in postmenopausal patients
However, the recently published SCORE2-Diabetes algorithm poses limitations owing to its non-categorisation of patients by Asian country, so the development of a CV risk score by nation would provide a link between the ESC guidelines and their recommendations for patients in each Asian country
Przepiorka D, Giralt S, Andreeff M , Huh YO, Luna M, Reading C, Thomas M, Champlin RE